Guanhao Biotech Co.,Ltd. (SHE:300238)
China · Delayed Price · Currency is CNY 14.12
-0.41 (-2.82%)
May 12, 2026, 3:04 PM CST
Guanhao Biotech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 19.64 | 24.35 | 27.42 | 31.01 | -307.82 | 73.69 |
Depreciation & Amortization | 25.31 | 25.31 | 26.86 | 29.01 | 33.04 | 38.8 |
Other Amortization | 1.29 | 1.29 | 1.01 | 5.96 | 8.09 | 11.03 |
Loss (Gain) From Sale of Assets | 0.01 | 0.01 | -0.03 | -0.92 | -0.03 | -0.33 |
Asset Writedown & Restructuring Costs | 0.08 | 0.08 | 4.98 | 0.29 | 217.94 | 0.19 |
Loss (Gain) From Sale of Investments | -1.89 | -1.89 | 10.23 | 3.64 | 41.36 | 4.68 |
Provision & Write-off of Bad Debts | 1.53 | 1.53 | 8.56 | 6.72 | 8.91 | 2.7 |
Other Operating Activities | -28.06 | -3.87 | -8.9 | 2.93 | 52.99 | -6.22 |
Change in Accounts Receivable | 17.76 | 17.76 | 19.96 | 11.12 | 40.05 | 14.17 |
Change in Inventory | -0.63 | -0.63 | -2.13 | -5.84 | 9.2 | -14.98 |
Change in Accounts Payable | 8.13 | 8.13 | -36.83 | -27.87 | -54.31 | -15.12 |
Operating Cash Flow | 42.58 | 71.47 | 49.55 | 54.15 | 70.98 | 122.39 |
Operating Cash Flow Growth | -20.79% | 44.23% | -8.49% | -23.71% | -42.00% | 17.87% |
Capital Expenditures | -26.03 | -38.17 | -76.2 | -53.92 | -41.17 | -4.71 |
Sale of Property, Plant & Equipment | 0.05 | 0.03 | 0.1 | 0.01 | 0.03 | 5.03 |
Cash Acquisitions | -0.9 | -0.9 | -3.56 | - | - | -0.15 |
Divestitures | - | - | - | 2.8 | -0.77 | -0.13 |
Investment in Securities | 2.84 | 2.84 | -5.28 | - | 1.89 | 2.66 |
Other Investing Activities | 2.44 | - | - | - | - | - |
Investing Cash Flow | -21.6 | -36.19 | -84.95 | -51.11 | -40.02 | 2.7 |
Short-Term Debt Issued | - | - | - | - | - | 52 |
Long-Term Debt Issued | - | 45.01 | 85 | 37.5 | 50 | - |
Total Debt Issued | 32.28 | 45.01 | 85 | 37.5 | 50 | 52 |
Short-Term Debt Repaid | - | - | - | - | - | -153.25 |
Long-Term Debt Repaid | - | -26.43 | -38.94 | -63.62 | -116.97 | -13.05 |
Total Debt Repaid | -27.02 | -26.43 | -38.94 | -63.62 | -116.97 | -166.3 |
Net Debt Issued (Repaid) | 5.26 | 18.59 | 46.06 | -26.12 | -66.97 | -114.3 |
Issuance of Common Stock | - | 6.1 | - | - | - | - |
Common Dividends Paid | -3.58 | -3.67 | -2.46 | -1.21 | -3.68 | -6.97 |
Other Financing Activities | 0.11 | - | - | - | - | -0.5 |
Financing Cash Flow | 1.79 | 21.02 | 43.59 | -27.32 | -70.65 | -121.78 |
Foreign Exchange Rate Adjustments | -0.4 | -0.18 | 0.18 | 0.08 | 0.69 | -0.21 |
Net Cash Flow | 22.37 | 56.12 | 8.38 | -24.21 | -38.99 | 3.11 |
Free Cash Flow | 16.55 | 33.3 | -26.65 | 0.23 | 29.81 | 117.68 |
Free Cash Flow Growth | - | - | - | -99.22% | -74.67% | 16.59% |
Free Cash Flow Margin | 4.28% | 8.59% | -7.06% | 0.06% | 7.90% | 24.07% |
Free Cash Flow Per Share | 0.06 | 0.12 | -0.10 | 0.00 | 0.11 | 0.45 |
Cash Income Tax Paid | 44.73 | 44.73 | 38.77 | 46.56 | 39.93 | 30.81 |
Levered Free Cash Flow | 27.91 | 14.06 | -13.68 | 24.86 | 52.4 | 85.69 |
Unlevered Free Cash Flow | 30.38 | 16.58 | -13.03 | 25.97 | 54.97 | 90.3 |
Change in Working Capital | 24.67 | 24.67 | -20.57 | -24.47 | 16.49 | -2.15 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.